Marcus F. Boehm
Gründer bei Escient Pharmaceuticals, Inc.
Profil
Dr. Marcus F.
Boehm is an Executive Advisor at Escient Pharmaceuticals, Inc. He is on the Board of Directors at UC San Diego Foundation.
Dr. Boehm was previously employed as an Independent Director by Vyant Bio, Inc., a Chief Technology Officer by Receptos, Inc., a Vice President-Chemistry by Apoptos, Inc., a Vice President-Chemistry by Conforma Therapeutics Corp., and an Associate Director-Medicinal Chemistry by Ligand Pharmaceuticals, Inc. He also served on the board at StemoniX, Inc.
He received his undergraduate degree from the University of California San Diego and a doctorate degree from Stony Brook University.
Aktive Positionen von Marcus F. Boehm
| Unternehmen | Position | Beginn |
|---|---|---|
Escient Pharmaceuticals, Inc.
 Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | Gründer | - |
UC San Diego Foundation
 UC San Diego Foundation Investment Trusts/Mutual FundsMiscellaneous UC San Diego Foundation specializes in obtaining private gifts in support of research, teaching, and public service, as well as engages in management of gift assets. The company is was founded in 1972 and is headquartered in La Jolla, CA. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Marcus F. Boehm
| Unternehmen | Position | Ende |
|---|---|---|
| VYANT BIO, INC. | Direktor/Vorstandsmitglied | 14.07.2022 |
| RECEPTOS INC | Gründer | 27.08.2015 |
Apoptos, Inc.
 Apoptos, Inc. Pharmaceuticals: MajorHealth Technology Apoptos, Inc. discovers and develops small molecule anticancer drugs. The company focuses in drug therapies that directly induce tumor cell apoptosis. It was founded in 2007 and is headquartered in San Diego, CA | Gründer | 01.05.2009 |
Conforma Therapeutics Corp.
 Conforma Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Conforma Therapeutics Corp. designs and develops drugs for treatment of cancer. It also develops applications in the areas of medicine, including inflammation, virology and central nervous system disorders. The company was founded in 1999 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
StemoniX, Inc.
 StemoniX, Inc. Miscellaneous Commercial ServicesCommercial Services StemoniX, Inc. provides IPS-based platforms for pharmacy and research institutions. It offers microBrain 3D Assay Ready, microBrain 2D Assay Ready, microPlate, microHeart Assay Ready, and microHeart Cell Ready. The company was founded by Yung-Ping Yeh and Robert Petcavich in 2014 and is headquartered in Maple Grove, MN. | Direktor/Vorstandsmitglied | - |
Ausbildung von Marcus F. Boehm
| University of California San Diego | Undergraduate Degree |
| Stony Brook University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| VYANT BIO, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Conforma Therapeutics Corp.
Conforma Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Conforma Therapeutics Corp. designs and develops drugs for treatment of cancer. It also develops applications in the areas of medicine, including inflammation, virology and central nervous system disorders. The company was founded in 1999 and is headquartered in Cambridge, MA. | Health Technology |
Receptos LLC
 Receptos LLC Pharmaceuticals: MajorHealth Technology Receptos LLC engages in the provision of developing and commercializing of therapeutic candidates for the treatment of immune and inflammatory diseases. It offers Ozanimod for relapsing multiple sclerosis, Ozanimod for inflammatory bowel disease and RPC4046 for eosinophilic esophagitis. The company was founded by Marcus F. Boehm, Robert J. Peach, William H. Rastetter, Hugh Rosen and Raymond C. Stevens on September 26, 2008 and is headquartered in San Diego, CA. | Health Technology |
Apoptos, Inc.
Apoptos, Inc. Pharmaceuticals: MajorHealth Technology Apoptos, Inc. discovers and develops small molecule anticancer drugs. The company focuses in drug therapies that directly induce tumor cell apoptosis. It was founded in 2007 and is headquartered in San Diego, CA | Health Technology |
Escient Pharmaceuticals, Inc.
Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | Health Technology |
UC San Diego Foundation
UC San Diego Foundation Investment Trusts/Mutual FundsMiscellaneous UC San Diego Foundation specializes in obtaining private gifts in support of research, teaching, and public service, as well as engages in management of gift assets. The company is was founded in 1972 and is headquartered in La Jolla, CA. | Miscellaneous |
StemoniX, Inc.
StemoniX, Inc. Miscellaneous Commercial ServicesCommercial Services StemoniX, Inc. provides IPS-based platforms for pharmacy and research institutions. It offers microBrain 3D Assay Ready, microBrain 2D Assay Ready, microPlate, microHeart Assay Ready, and microHeart Cell Ready. The company was founded by Yung-Ping Yeh and Robert Petcavich in 2014 and is headquartered in Maple Grove, MN. | Commercial Services |
